Structural biology of prions.

[1]  Xudong Huang,et al.  Dramatic Aggregation of Alzheimer Aβ by Cu(II) Is Induced by Conditions Representing Physiological Acidosis* , 1998, The Journal of Biological Chemistry.

[2]  P. Roller,et al.  Scrapie amyloid (prion) protein has the conformational characteristics of an aggregated molten globule folding intermediate. , 1994, Biochemistry.

[3]  F. Heppner,et al.  Absence of the prion protein homologue Doppel causes male sterility , 2002, The EMBO journal.

[4]  Fran Maher,et al.  The Hydrophobic Core Sequence Modulates the Neurotoxic and Secondary Structure Properties of the Prion Peptide 106‐126 , 1999, Journal of neurochemistry.

[5]  Inyoul Y. Lee,et al.  Complete genomic sequence and analysis of the prion protein gene region from three mammalian species. , 1998, Genome research.

[6]  S. Prusiner,et al.  Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein , 1992, Nature.

[7]  G. Edelman,et al.  Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. , 2001, Journal of molecular biology.

[8]  F. Cohen,et al.  Prion protein selectively binds copper(II) ions. , 1998, Biochemistry.

[9]  G. Forloni,et al.  Conformational polymorphism of the amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. , 1994, The Journal of biological chemistry.

[10]  R. Petersen,et al.  Effect of the D178N Mutation and the Codon 129 Polymorphism on the Metabolism of the Prion Protein (*) , 1996, The Journal of Biological Chemistry.

[11]  W. Surewicz,et al.  pH-dependent Stability and Conformation of the Recombinant Human Prion Protein PrP(90–231)* , 1997, The Journal of Biological Chemistry.

[12]  B. Chesebro,et al.  Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain , 1985, Nature.

[13]  R. Lebo,et al.  Human prion protein cDNA: molecular cloning, chromosomal mapping, and biological implications. , 1986, Science.

[14]  J. Lakey,et al.  Copper binding to the N-terminal tandem repeat region of mammalian and avian prion protein: structural studies using synthetic peptides. , 1995, Biochemical and biophysical research communications.

[15]  S. Prusiner,et al.  Separation and properties of cellular and scrapie prion proteins. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[16]  D. Dormont,et al.  The 37‐kDa/67‐kDa laminin receptor acts as the cell‐surface receptor for the cellular prion protein , 2001, The EMBO journal.

[17]  D. Harris,et al.  Copper Stimulates Endocytosis of the Prion Protein* , 1998, The Journal of Biological Chemistry.

[18]  J Collinge,et al.  Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations. , 1999, Science.

[19]  P. Roller,et al.  Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein. , 1993, The Journal of biological chemistry.

[20]  Neena Singh,et al.  Prion Peptide 106–126 Modulates the Aggregation of Cellular Prion Protein and Induces the Synthesis of Potentially Neurotoxic Transmembrane PrP* , 2002, The Journal of Biological Chemistry.

[21]  J. Collinge,et al.  Structural mobility of the human prion protein probed by backbone hydrogen exchange , 1999, Nature Structural Biology.

[22]  H. Takeuchi,et al.  Raman spectroscopic study on the copper(II) binding mode of prion octapeptide and its pH dependence. , 1999, Biochemistry.

[23]  R. Riek,et al.  Prion protein NMR structure and species barrier for prion diseases. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R. Glockshuber,et al.  Electron paramagnetic resonance evidence for binding of Cu(2+) to the C-terminal domain of the murine prion protein. , 2001, Biophysical journal.

[25]  Bernhard Schmidt,et al.  Role of microglia and host prion protein in neurotoxicity of a prion protein fragment , 1996, Nature.

[26]  A. Bush,et al.  Copper and zinc binding modulates the aggregation and neurotoxic properties of the prion peptide PrP106-126. , 2001, Biochemistry.

[27]  S. Prusiner,et al.  Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[28]  F. Cohen,et al.  Copper binding to octarepeat peptides of the prion protein monitored by mass spectrometry , 2008, Protein science : a publication of the Protein Society.

[29]  J. Mcdermott,et al.  Copper binding to the N-terminal tandem repeat regions of mammalian and avian prion protein. , 1995, Biochemical and biophysical research communications.

[30]  Inyoul Y. Lee,et al.  Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel. , 1999, Journal of molecular biology.

[31]  F. Cohen,et al.  Copper binding to the prion protein: structural implications of four identical cooperative binding sites. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[32]  S. Mead,et al.  Two-octapeptide repeat deletion of prion protein associated with rapidly progressive dementia , 2001, Neurology.

[33]  S. Haswell,et al.  Consequences of manganese replacement of copper for prion protein function and proteinase resistance , 2000, The EMBO journal.

[34]  F. Cohen,et al.  Physical studies of conformational plasticity in a recombinant prion protein. , 1997, Biochemistry.

[35]  F. Cohen,et al.  Recombinant scrapie-like prion protein of 106 amino acids is soluble. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[36]  J. Collinge,et al.  XAFS study of the high-affinity copper-binding site of human PrP(91-231) and its low-resolution structure in solution. , 2001, Journal of molecular biology.

[37]  A. Burlingame,et al.  Stress‐inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection , 2002, The EMBO journal.

[38]  Eliah Aronoff-Spencer,et al.  Molecular features of the copper binding sites in the octarepeat domain of the prion protein. , 2002, Biochemistry.

[39]  D. Harris,et al.  Mutant and Infectious Prion Proteins Display Common Biochemical Properties in Cultured Cells (*) , 1996, The Journal of Biological Chemistry.

[40]  A. Bush,et al.  Metals and neuroscience. , 2000, Current opinion in chemical biology.

[41]  S. Prusiner,et al.  Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice. , 1996, Genes & development.

[42]  K Wüthrich,et al.  NMR solution structure of the human prion protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[43]  F. Cohen,et al.  Differences between the prion protein and its homolog Doppel: a partially structured state with implications for scrapie formation. , 2002, Journal of molecular biology.

[44]  M. Palmer,et al.  Deletions in the prion protein gene are not associated with CJD. , 1993, Human molecular genetics.

[45]  Ruedi Aebersold,et al.  A cellular gene encodes scrapie PrP 27-30 protein , 1985, Cell.

[46]  D. Westaway,et al.  Mapping Cu(II) Binding Sites in Prion Proteins by Diethyl Pyrocarbonate Modification and Matrix-assisted Laser Desorption Ionization-Time of Flight (MALDI-TOF) Mass Spectrometric Footprinting* , 2002, The Journal of Biological Chemistry.

[47]  K Wüthrich,et al.  NMR structure of the bovine prion protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[48]  J. Collinge,et al.  Strain-specific prion-protein conformation determined by metal ions , 1999, Nature Cell Biology.

[49]  S. Prusiner,et al.  Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene , 1986, Cell.

[50]  N. Hooper,et al.  Ablation of the metal ion-induced endocytosis of the prion protein by disease-associated mutation of the octarepeat region , 2001, Current Biology.

[51]  F. Cohen,et al.  X-ray diffraction of scrapie prion rods and PrP peptides. , 1995, Journal of molecular biology.

[52]  Witold K. Surewicz,et al.  Crystal structure of the human prion protein reveals a mechanism for oligomerization , 2002, Nature Structural Biology.

[53]  R. Casareno,et al.  Brain Copper Content and Cuproenzyme Activity Do Not Vary with Prion Protein Expression Level* , 2000, The Journal of Biological Chemistry.

[54]  Carl W. Cotman,et al.  Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[55]  F. Cohen,et al.  Eight prion strains have PrPSc molecules with different conformations , 1998, Nature Medicine.

[56]  R. Riek,et al.  NMR structure of the mouse prion protein domain PrP(121–231) , 1996, Nature.

[57]  B. Ghetti,et al.  Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[58]  B. Caughey,et al.  Prion protein interconversions and the transmissible spongiform encephalopathies. , 1999, Structure.

[59]  R J Fletterick,et al.  Structural clues to prion replication. , 1994, Science.

[60]  W. Surewicz,et al.  Membrane Environment Alters the Conformational Structure of the Recombinant Human Prion Protein* , 1999, The Journal of Biological Chemistry.

[61]  C. Cotman,et al.  Structure‐Activity Analyses of β‐Amyloid Peptides: Contributions of the β25–35 Region to Aggregation and Neurotoxicity , 1995 .

[62]  H. Schätzl,et al.  PrPC Directly Interacts with Proteins Involved in Signaling Pathways* , 2001, The Journal of Biological Chemistry.

[63]  H. Kretzschmar,et al.  Mouse cortical cells lacking cellular PrP survive in culture with a neurotoxic PrP fragment , 1994, Neuroreport.

[64]  R J Fletterick,et al.  Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[65]  Xudong Huang,et al.  Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42. , 2008, Journal of neurochemistry.

[66]  P. Lansbury,et al.  Aggregates of scrapie-associated prion protein induce the cell-free conversion of protease-sensitive prion protein to the protease-resistant state. , 1995, Chemistry & biology.

[67]  T. Noda,et al.  Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene , 1996, Nature.

[68]  R. Glockshuber,et al.  Extremely rapid folding of the C-terminal domain of the prion protein without kinetic intermediates , 1999, Nature Structural Biology.

[69]  R. Glockshuber,et al.  Folding and intrinsic stability of deletion variants of PrP(121-231), the folded C-terminal domain of the prion protein. , 2002, Biophysical chemistry.

[70]  S. Prusiner,et al.  A transmembrane form of the prion protein in neurodegenerative disease. , 1998, Science.

[71]  T. Pinheiro,et al.  Binding of prion protein to lipid membranes and implications for prion conversion. , 2002, Journal of molecular biology.

[72]  R. Riek,et al.  Recombinant full‐length murine prion protein, mPrP(23–231): purification and spectroscopic characterization , 1997, FEBS letters.

[73]  T. Werner,et al.  Analysis of 27 mammalian and 9 avian PrPs reveals high conservation of flexible regions of the prion protein. , 1999, Journal of molecular biology.

[74]  F E Cohen,et al.  Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[75]  S. Prusiner,et al.  Ultrastructural studies on scrapie prion protein crystals obtained from reverse micellar solutions. , 1999, Biophysical journal.

[76]  J. Collinge,et al.  Location and properties of metal-binding sites on the human prion protein , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[77]  K. Beyreuther,et al.  Prion protein-deficient neurons reveal lower glutathione reductase activity and increased susceptibility to hydrogen peroxide toxicity. , 1999, The American journal of pathology.

[78]  P E Wright,et al.  Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[79]  F. Cohen,et al.  Two different neurodegenerative diseases caused by proteins with similar structures , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[80]  B. Chesebro,et al.  Conversion of raft associated prion protein to the protease‐resistant state requires insertion of PrP‐res (PrPSc) into contiguous membranes , 2002, The EMBO journal.

[81]  W. Surewicz,et al.  Familial Mutations and the Thermodynamic Stability of the Recombinant Human Prion Protein* , 1998, The Journal of Biological Chemistry.

[82]  G. Forloni,et al.  Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. , 1993, Biochemical and biophysical research communications.

[83]  F. Cohen,et al.  High-level expression and characterization of a purified 142-residue polypeptide of the prion protein. , 1996, Biochemistry.

[84]  David A Agard,et al.  Structural studies of the scrapie prion protein by electron crystallography , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[85]  B. Ghetti,et al.  Accumulation of protease-resistant prion protein (PrP) and apoptosis of cerebellar granule cells in transgenic mice expressing a PrP insertional mutation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[86]  D. Brown.  PrPSc-like prion protein peptide inhibits the function of cellular prion protein. , 2000, The Biochemical journal.

[87]  M. Palmer,et al.  Prion protein is necessary for normal synaptic function , 1994, Nature.

[88]  S. Prusiner.  Novel proteinaceous infectious particles cause scrapie. , 1982, Science.

[89]  H. Takeuchi,et al.  Metal‐dependent α‐helix formation promoted by the glycine‐rich octapeptide region of prion protein , 1996, FEBS letters.

[90]  D. Westaway,et al.  The cellular prion protein binds copper in vivo , 1997, Nature.

[91]  S. Itohara,et al.  Prions prevent neuronal cell-line death , 1999, Nature.

[92]  F. Cohen,et al.  Solution structure of Syrian hamster prion protein rPrP(90-231). , 1999, Biochemistry.

[93]  J. Reed,et al.  Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease beta A4 peptides. , 1992, Journal of molecular biology.

[94]  D. Dormont,et al.  Identification of interaction domains of the prion protein with its 37‐kDa/67‐kDa laminin receptor , 2001, The EMBO journal.

[95]  P. Lansbury,et al.  Partial unfolding and refolding of scrapie-associated prion protein: evidence for a critical 16-kDa C-terminal domain. , 1996, Biochemistry.

[96]  G. Forloni,et al.  Neurotoxicity of a prion protein fragment , 1993, Nature.

[97]  F E Cohen,et al.  A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform. , 1997, Journal of molecular biology.

[98]  K Wüthrich,et al.  NMR characterization of the full‐length recombinant murine prion protein, mPrP(23–231) , 1997, FEBS letters.